GRP
BCAX

Global Retirement Partners’s Bicara Therapeutics BCAX Stock Holding History

Global Retirement Partners’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.99K Buy
118
+13
+12% +$222 ﹤0.01% 3735
2025
Q3 		$1.66K Buy
+105
New +$1.18K ﹤0.01% 3376

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Global Retirement Partners's BCAX Position: Q4 2025 in Review

Global Retirement Partners increased its Bicara Therapeutics (BCAX) stake by 12% in Q4 2025, buying an estimated $222 and bringing the position to 118 shares worth $1.99K. The position accounts for ﹤0.01% of the portfolio, ranked #3735.

Global Retirement Partners first reported a position in BCAX in Q3 2025 and has held it in 2 quarters since. 141 funds tracked by Wall St. Rank hold BCAX as of Q4 2025.

  • Global Retirement Partners held 118 shares of Bicara Therapeutics worth $1.99K as of Q4 2025.
  • Global Retirement Partners bought 13 Bicara Therapeutics shares in Q4 2025, an estimated $222.
  • Bicara Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3735 holding.
  • Global Retirement Partners first reported a position in Bicara Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 141 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.